Clinical Trials Directory

Trials / Recruiting

RecruitingNCT03647098

Survival Outcomes of Lung Cancer

Survival Outcomes for Lung Cancer

Status
Recruiting
Phase
Study type
Observational
Enrollment
20,000 (estimated)
Sponsor
Hunan Province Tumor Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a prospective study to analyze the survival outcomes of different groups about lung cancer patients.

Detailed description

This study aims to analyze the survival outcomes of different groups about lung cancer patients. All the groups were assessed to the treatment decisions guided by molecular profiling and clinical judgment of principal investigators

Conditions

Interventions

TypeNameDescription
DRUGTreatmentTreatment decisions guided by molecular profiling and clinical judgment of principal investigators

Timeline

Start date
2018-08-01
Primary completion
2028-12-31
Completion
2030-12-31
First posted
2018-08-27
Last updated
2025-02-14

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03647098. Inclusion in this directory is not an endorsement.

Survival Outcomes of Lung Cancer (NCT03647098) · Clinical Trials Directory